Annual Cash & Cash Equivalents
$8.45 M
-$1.99 M-19.09%
June 1, 2024
Summary
- As of February 26, 2025, ATHE annual cash & cash equivalents is $8.45 million, with the most recent change of -$1.99 million (-19.09%) on June 1, 2024.
- During the last 3 years, ATHE annual cash & cash equivalents has fallen by -$12.68 million (-60.01%).
- ATHE annual cash & cash equivalents is now -73.74% below its all-time high of $32.17 million, reached on June 30, 2014.
Performance
ATHE Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$8.45 M
-$1.99 M-19.09%
June 1, 2024
Summary
- As of February 26, 2025, ATHE quarterly cash and cash equivalents is $8.45 million, with the most recent change of -$1.99 million (-19.09%) on June 1, 2024.
- Over the past year, ATHE quarterly cash and cash equivalents has stayed the same.
- ATHE quarterly cash and cash equivalents is now -73.74% below its all-time high of $32.17 million, reached on June 30, 2014.
Performance
ATHE Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ATHE Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.1% | 0.0% |
| 3 y3 years | -60.0% | -64.7% |
| 5 y5 years | -16.2% | -16.2% |
ATHE Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.7% | at low | -68.5% | at low |
| 5 y | 5-year | -64.7% | +33.7% | -68.7% | at low |
| alltime | all time | -73.7% | -100.0% | -73.7% | +940.8% |
Alterity Therapeutics Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | $8.45 M(-19.1%) | $8.45 M(-19.1%) |
| Jun 2023 | $10.44 M(-56.4%) | $10.44 M(-39.4%) |
| Dec 2022 | - | $17.24 M(-28.0%) |
| Jun 2022 | $23.94 M(+13.3%) | $23.94 M(-10.7%) |
| Dec 2021 | - | $26.82 M(+27.0%) |
| Jun 2021 | $21.12 M(+234.3%) | $21.12 M(-21.6%) |
| Dec 2020 | - | $26.94 M(+216.0%) |
| Jun 2020 | $6.32 M(-37.3%) | - |
| Dec 2019 | - | $8.53 M(-15.5%) |
| Jun 2019 | $10.08 M(-9.9%) | $10.08 M(+70.8%) |
| Dec 2018 | - | $5.91 M(-47.2%) |
| Jun 2018 | $11.19 M(-33.5%) | $11.19 M(-27.9%) |
| Dec 2017 | - | $15.53 M(-7.7%) |
| Jun 2017 | $16.82 M(-21.2%) | $16.82 M(-18.0%) |
| Dec 2016 | - | $20.50 M(-3.1%) |
| Jun 2016 | $21.35 M(-20.3%) | - |
| Dec 2015 | - | $21.16 M(-21.0%) |
| Jun 2015 | $26.78 M(-16.8%) | $26.78 M(+12.6%) |
| Dec 2014 | - | $23.77 M(-26.1%) |
| Jun 2014 | $32.17 M(+159.7%) | $32.17 M(+86.9%) |
| Dec 2013 | - | $17.21 M(+39.0%) |
| Jun 2013 | $12.38 M(+119.0%) | $12.38 M(+34.8%) |
| Dec 2012 | - | $9.19 M(+62.4%) |
| Jun 2012 | $5.66 M | $5.66 M(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $6.84 M(-27.6%) |
| Jun 2011 | $9.45 M(+114.9%) | $9.45 M(+222.8%) |
| Dec 2010 | - | $2.93 M(-33.4%) |
| Jun 2010 | $4.40 M(+26.7%) | $4.40 M(-41.5%) |
| Dec 2009 | - | $7.51 M(+116.6%) |
| Jun 2009 | $3.47 M(-67.7%) | $3.47 M(-37.3%) |
| Dec 2008 | - | $5.54 M(-48.5%) |
| Jun 2008 | $10.74 M(+71.1%) | $10.74 M(+33.9%) |
| Dec 2007 | - | $8.02 M(+27.8%) |
| Jun 2007 | $6.28 M(-15.5%) | $6.28 M(-31.0%) |
| Dec 2006 | - | $9.11 M(+22.5%) |
| Jun 2006 | $7.44 M(-54.3%) | $7.44 M(-35.5%) |
| Dec 2005 | - | $11.53 M(-29.2%) |
| Jun 2005 | $16.28 M(-20.5%) | $16.28 M(-22.6%) |
| Dec 2004 | - | $21.04 M(+2.7%) |
| Jun 2004 | $20.49 M(+781.6%) | $20.49 M(+384.8%) |
| Dec 2003 | - | $4.23 M(+81.8%) |
| Jun 2003 | $2.32 M(+15.1%) | $2.32 M(+186.3%) |
| Dec 2002 | - | $811.70 K |
| Jun 2002 | $2.02 M(-42.3%) | - |
| Jun 2001 | $3.50 M(+31.2%) | - |
| Jun 2000 | $2.67 M(>+9900.0%) | - |
| Jun 1999 | $0.00(0.0%) | - |
| Jun 1998 | $0.00 | - |
FAQ
- What is Alterity Therapeutics Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Alterity Therapeutics Limited?
- What is Alterity Therapeutics Limited annual cash & cash equivalents year-on-year change?
- What is Alterity Therapeutics Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Alterity Therapeutics Limited?
- What is Alterity Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
What is Alterity Therapeutics Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of ATHE is $8.45 M
What is the all time high annual cash & cash equivalents for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high annual cash & cash equivalents is $32.17 M
What is Alterity Therapeutics Limited annual cash & cash equivalents year-on-year change?
Over the past year, ATHE annual cash & cash equivalents has changed by -$1.99 M (-19.09%)
What is Alterity Therapeutics Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ATHE is $8.45 M
What is the all time high quarterly cash and cash equivalents for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high quarterly cash and cash equivalents is $32.17 M
What is Alterity Therapeutics Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, ATHE quarterly cash and cash equivalents has changed by $0.00 (0.00%)